NCT00003440
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +8 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
Clinical trial condition
HER2-negative Breast Cancer
Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.
108 public trials
54 recruiting studies
HER2-negative Breast Cancer trial results
Active, Not Recruiting
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
NCT05607004
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen-receptor-positive Breast Cancer, +6 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- University of Arizona Tucson, Arizona, United States
- California Research Institute Los Angeles, California, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
Active, Not Recruiting
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
NCT01953588
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
NCT05889390
- Conditions
- Body Temperature Changes, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University Budapest, Hungary
Active, Not Recruiting
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
NCT04584255
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Yale University Cancer Center New Haven, Connecticut, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, Not Recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +6 more
- Locations
-
- MUG - Univ.-Klinik f. Frauenheilkunde u. Geburtshilfe Graz Graz, Austria
- MUG - Univ.-Klinik f. Innere Medizin Graz Graz, Austria
- MUI - Univ. Klinik f. Frauenheilkunde Innsbruck Innsbruck, Austria
- Ordensklinikum Linz GmbH - BHS Linz, Austria
Active, Not Recruiting
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
NCT06590857
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Research Facility Phoenix, Arizona, United States
- Research Facility Irvine, California, United States
- Research Facility San Diego, California, United States
- Research Facility Santa Monica, California, United States
Active, Not Recruiting
Onvansertib + Paclitaxel In TNBC
NCT05383196
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
NCT04448886
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +7 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- DFCI @ Foxborough Foxborough, Massachusetts, United States
Active, Not Recruiting
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
NCT06334432
- Conditions
- Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- Karmanos Cancer Center Detroit, Michigan, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Carolina BioOncology Institute Huntersville, North Carolina, United States